Ledipasvir plus sofosbuvir: Hint of added benefit in further patient group

Documents subsequently submitted by the manufacturer show an advantage in sustained virologic response also for hepatitis C infection of genotype 1 with HIV coinfection without cirrhosis of the liver, reviewers report.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1IPsCUT